ISIS 2302 antisense inhibitor of intercellular adhesion molecule 1: Phase IIa trial

Isis Pharmaceuticals (ISIP), Carlsbad, Calif.
Product:

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE